9/23/2026
NeuroThera expands U.S. patents for psychedelic therapies
New patents cover LSD, ketamine, ibogaine combinations for mental health.
Topic archive
3 stories
9/23/2026
New patents cover LSD, ketamine, ibogaine combinations for mental health.
9/23/2026
Collaboration with Clearmind Medicine enhances therapeutic potential for mental health and substance use disorders.
9/23/2026
New patent applications aim to enhance mental health treatments using LSD, ketamine, ibogaine.